Life Science Investment Summit takes applications for seed-stage funding

By The Science Advisory Board staff writers

December 13, 2021 -- Applied Pharmaceutical Innovation (API), a nonprofit life sciences institute, has partnered with Startup TNT, an Alberta-based nonprofit and startup community to build the Startup TNT Life Sciences Investment Summit, a platform for life sciences entrepreneurs and innovators seeking seed-stage funding.

This summit will provide entrepreneurs with an opportunity to receive seed funding for their idea or business, and to network with investors and representatives from the startup and the life sciences ecosystem. The summit also offers hands-on training for investors interested in life sciences through a team-based due diligence process.

Startup TNT will leverage its expertise in building a community of entrepreneurs, scientists, investors, innovators, and startup supporters, to help lead the application and the due diligence process. In their last summit in November 2021, Startup TNT successfully raised $1.4 million to fund 10 companies, of which 40% were founded and led by women.

API will leverage its network of experts in life sciences and pharmaceutical industry to garner support of new and seasoned investors, participate in the startup recruitment process and secure base level funding for the summit.

The Life Sciences Investment Summit will be an open call, but the requirement is that companies have a presence in Alberta through active or planned contracts or employees in the province.

Interested parties can apply until January 18, 2022. Applicants shortlisted by the investors will be invited to participate in an eight-week due diligence process starting January 2022 to March 2022. A final pitch event will be held on March 17, 2022.

Copyright © 2021
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for

Already have an account? Sign in here